Phase 2 Efficacy and Safety Study of Intravenous GPX-150, an Anthracycline Analog, in Patients With Soft Tissue Sarcoma
Phase of Trial: Phase II
Latest Information Update: 12 Jan 2018
Price : $35 *
At a glance
- Drugs Camsirubicin (Primary)
- Indications Soft tissue sarcoma
- Focus Therapeutic Use
- Sponsors Gem Pharmaceuticals
- 14 Nov 2017 Results published in the Monopar Therapeutics Media Release.
- 22 Feb 2017 Status changed from active, no longer recruiting to completed.
- 07 Jun 2016 Results presented at the 52nd Annual Meeting of the American Society of Clinical Oncology